Request for Covid-19 Impact Assessment of this Report
Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units) , revenue (Million USD) , market share and growth rate of Nuclear Medicine/Radiopharmaceuticals for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.
EMEA Nuclear Medicine/Radiopharmaceuticals market competition by top manufacturers/players, with Nuclear Medicine/Radiopharmaceuticals sales volume (K Units) , price (USD/Unit) , revenue (Million USD) and market share for each manufacturer/player; the top players including
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Triad Isotopes
Nordion
Jubilant Pharma
Eli Lilly
Siemens
China Isotope & Radiation
Dongcheng
On the basis of product, this report displays the sales volume (K Units) , revenue (Million USD) , product price (USD/Unit) , market share and growth rate of each type, primarily split into
Diagnostic
Therapeutic
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units) , market share and growth rate of Nuclear Medicine/Radiopharmaceuticals for each application, including
Oncology
Thyroid
Cardiology
Other
EMEA (Europe, Middle East and Africa) Nuclear Medicine/Radiopharmaceuticals Market Report 2017
1 Nuclear Medicine/Radiopharmaceuticals Overview
1.1 Product Overview and Scope of Nuclear Medicine/Radiopharmaceuticals
1.2 Classification of Nuclear Medicine/Radiopharmaceuticals
1.2.1 EMEA Nuclear Medicine/Radiopharmaceuticals Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Nuclear Medicine/Radiopharmaceuticals Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Diagnostic
1.2.4 Therapeutic
1.3 EMEA Nuclear Medicine/Radiopharmaceuticals Market by Application/End Users
1.3.1 EMEA Nuclear Medicine/Radiopharmaceuticals Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Oncology
1.3.3 Thyroid
1.3.4 Cardiology
1.3.5 Other
1.4 EMEA Nuclear Medicine/Radiopharmaceuticals Market by Region
1.4.1 EMEA Nuclear Medicine/Radiopharmaceuticals Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Nuclear Medicine/Radiopharmaceuticals (2012-2022)
1.5.1 EMEA Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2012-2022)
1.5.2 EMEA Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2012-2022)
2 EMEA Nuclear Medicine/Radiopharmaceuticals Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Nuclear Medicine/Radiopharmaceuticals Market Competition by Players/Manufacturers
2.1.1 EMEA Nuclear Medicine/Radiopharmaceuticals Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Nuclear Medicine/Radiopharmaceuticals Revenue and Share by Players (2012-2017)
2.1.3 EMEA Nuclear Medicine/Radiopharmaceuticals Sale Price by Players (2012-2017)
2.2 EMEA Nuclear Medicine/Radiopharmaceuticals (Volume and Value) by Type/Product Category
2.2.1 EMEA Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Nuclear Medicine/Radiopharmaceuticals Sale Price by Type (2012-2017)
2.3 EMEA Nuclear Medicine/Radiopharmaceuticals (Volume) by Application
2.4 EMEA Nuclear Medicine/Radiopharmaceuticals (Volume and Value) by Region
2.4.1 EMEA Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Nuclear Medicine/Radiopharmaceuticals Sales Price by Region (2012-2017)
3 Europe Nuclear Medicine/Radiopharmaceuticals (Volume, Value and Sales Price) , by Players, Countries, Type and Application
3.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales and Value (2012-2017)
3.1.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2012-2017)
3.2 Europe Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Type
3.3 Europe Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Application
3.4 Europe Nuclear Medicine/Radiopharmaceuticals Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales Volume by Countries (2012-2017)
3.4.2 Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2012-2017)
3.4.3 Germany Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2012-2017)
3.4.4 France Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2012-2017)
3.4.5 UK Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2012-2017)
3.4.6 Russia Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2012-2017)
3.4.7 Italy Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2012-2017)
3.4.8 Benelux Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2012-2017)
4 Middle East Nuclear Medicine/Radiopharmaceuticals (Volume, Value and Sales Price) , by Region, Type and Application
4.1 Middle East Nuclear Medicine/Radiopharmaceuticals Sales and Value (2012-2017)
4.1.1 Middle East Nuclear Medicine/Radiopharmaceuticals Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2012-2017)
4.2 Middle East Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Type
4.3 Middle East Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Application
4.4 Middle East Nuclear Medicine/Radiopharmaceuticals Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Nuclear Medicine/Radiopharmaceuticals Sales Volume by Countries (2012-2017)
4.4.2 Middle East Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2012-2017)
4.4.4 Israel Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2012-2017)
4.4.5 UAE Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2012-2017)
4.4.6 Iran Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2012-2017)
5 Africa Nuclear Medicine/Radiopharmaceuticals (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Nuclear Medicine/Radiopharmaceuticals Sales and Value (2012-2017)
5.1.1 Africa Nuclear Medicine/Radiopharmaceuticals Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2012-2017)
5.2 Africa Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Type
5.3 Africa Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Application
5.4 Africa Nuclear Medicine/Radiopharmaceuticals Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Nuclear Medicine/Radiopharmaceuticals Sales Volume by Countries (2012-2017)
5.4.2 Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2012-2017)
5.4.3 South Africa Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2012-2017)
5.4.5 Egypt Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2012-2017)
5.4.6 Algeria Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2012-2017)
6 EMEA Nuclear Medicine/Radiopharmaceuticals Manufacturers/Players Profiles and Sales Data
6.1 GE Healthcare
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Nuclear Medicine/Radiopharmaceuticals Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 GE Healthcare Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Bracco Imaging
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Nuclear Medicine/Radiopharmaceuticals Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Bracco Imaging Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Mallinckrodt
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Nuclear Medicine/Radiopharmaceuticals Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Mallinckrodt Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Lantheus Medical Imaging
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Nuclear Medicine/Radiopharmaceuticals Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Bayer
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Nuclear Medicine/Radiopharmaceuticals Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Bayer Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Triad Isotopes
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Nuclear Medicine/Radiopharmaceuticals Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Triad Isotopes Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Nordion
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Nuclear Medicine/Radiopharmaceuticals Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Nordion Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Jubilant Pharma
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Nuclear Medicine/Radiopharmaceuticals Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Jubilant Pharma Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Eli Lilly
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Nuclear Medicine/Radiopharmaceuticals Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Eli Lilly Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Siemens
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Nuclear Medicine/Radiopharmaceuticals Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Siemens Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 China Isotope & Radiation
6.12 Dongcheng
7 Nuclear Medicine/Radiopharmaceuticals Manufacturing Cost Analysis
7.1 Nuclear Medicine/Radiopharmaceuticals Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceuticals
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Nuclear Medicine/Radiopharmaceuticals Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Nuclear Medicine/Radiopharmaceuticals Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 EMEA Nuclear Medicine/Radiopharmaceuticals Market Forecast (2017-2022)
11.1 EMEA Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Nuclear Medicine/Radiopharmaceuticals Price and Trend Forecast (2017-2022)
11.2 EMEA Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Type (2017-2022)
11.7 EMEA Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Application (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
Figure Product Picture of Nuclear Medicine/Radiopharmaceuticals
Figure EMEA Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Type (Product Category) in 2016
Figure Diagnostic Product Picture
Figure Therapeutic Product Picture
Figure EMEA Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Nuclear Medicine/Radiopharmaceuticals by Application in 2016
Figure Oncology Examples
Figure Thyroid Examples
Figure Cardiology Examples
Figure Other Examples
Figure EMEA Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Region (2012-2022)
Figure Europe Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) Status and Forecast by Countries
Figure Africa Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Nuclear Medicine/Radiopharmaceuticals Sales Volume and Growth Rate (2012-2022)
Figure EMEA Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Nuclear Medicine/Radiopharmaceuticals Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Nuclear Medicine/Radiopharmaceuticals Sales Share by Players (2012-2017)
Figure 2016 Nuclear Medicine/Radiopharmaceuticals Sales Share by Players
Figure 2017 Nuclear Medicine/Radiopharmaceuticals Sales Share by Players
Figure EMEA Nuclear Medicine/Radiopharmaceuticals Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) by Players (2012-2017)
Table EMEA Nuclear Medicine/Radiopharmaceuticals Revenue Share by Players (2012-2017)
Table 2016 EMEA Nuclear Medicine/Radiopharmaceuticals Revenue Share by Players
Table 2017 EMEA Nuclear Medicine/Radiopharmaceuticals Revenue Share by Players
Table EMEA Nuclear Medicine/Radiopharmaceuticals Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Nuclear Medicine/Radiopharmaceuticals Sales Share by Type (2012-2017)
Figure Sales Market Share of Nuclear Medicine/Radiopharmaceuticals by Type (2012-2017)
Figure EMEA Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2012-2017)
Table EMEA Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Nuclear Medicine/Radiopharmaceuticals Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Nuclear Medicine/Radiopharmaceuticals by Type in 2016
Table EMEA Nuclear Medicine/Radiopharmaceuticals Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Nuclear Medicine/Radiopharmaceuticals Sales Share by Application (2012-2017)
Figure Sales Market Share of Nuclear Medicine/Radiopharmaceuticals by Application (2012-2017)
Figure EMEA Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application in 2016
Table EMEA Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Nuclear Medicine/Radiopharmaceuticals Sales Share by Region (2012-2017)
Figure Sales Market Share of Nuclear Medicine/Radiopharmaceuticals by Region (2012-2017)
Figure EMEA Nuclear Medicine/Radiopharmaceuticals Sales Market Share in 2016
Table EMEA Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Nuclear Medicine/Radiopharmaceuticals Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Nuclear Medicine/Radiopharmaceuticals by Region (2012-2017)
Figure EMEA Nuclear Medicine/Radiopharmaceuticals Revenue Market Share Regions in 2016
Table EMEA Nuclear Medicine/Radiopharmaceuticals Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2012-2017)
Table Europe Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Type (2012-2017)
Table Europe Nuclear Medicine/Radiopharmaceuticals Market Share by Type (2012-2017)
Figure Europe Nuclear Medicine/Radiopharmaceuticals Market Share by Type in 2016
Table Europe Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Application (2012-2017)
Table Europe Nuclear Medicine/Radiopharmaceuticals Market Share by Application (2012-2017)
Figure Europe Nuclear Medicine/Radiopharmaceuticals Market Share by Application in 2016
Table Europe Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Countries (2012-2017)
Table Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2012-2017)
Figure Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2012-2017)
Figure Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries in 2016
Table Europe Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) by Countries (2012-2017)
Table Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries in 2016
Figure Germany Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure France Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure UK Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Type (2012-2017)
Table Middle East Nuclear Medicine/Radiopharmaceuticals Market Share by Type (2012-2017)
Figure Middle East Nuclear Medicine/Radiopharmaceuticals Market Share by Type (2012-2017)
Table Middle East Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Applications (2012-2017)
Table Middle East Nuclear Medicine/Radiopharmaceuticals Market Share by Applications (2012-2017)
Figure Middle East Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application in 2016
Table Middle East Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Countries in 2016
Table Middle East Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) by Countries (2012-2017)
Table Middle East Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Middle East Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Middle East Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries in 2016
Figure Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Type (2012-2017)
Table Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2012-2017)
Figure Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2012-2017)
Figure Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type in 2016
Table Africa Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Application (2012-2017)
Table Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2012-2017)
Figure Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2012-2017)
Table Africa Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) by Countries (2012-2017)
Table Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2012-2017)
Figure Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2012-2017)
Figure Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries in 2016
Table Africa Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) by Countries (2012-2017)
Table Africa Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Africa Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Africa Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries in 2016
Figure South Africa Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Table GE Healthcare Nuclear Medicine/Radiopharmaceuticals Basic Information List
Table GE Healthcare Nuclear Medicine/Radiopharmaceuticals Sales (K Units) , Revenue (Million USD) , Price (USD/Unit) and Gross Margin (2012-2017)
Figure GE Healthcare Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure GE Healthcare Nuclear Medicine/Radiopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure GE Healthcare Nuclear Medicine/Radiopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Bracco Imaging Nuclear Medicine/Radiopharmaceuticals Basic Information List
Table Bracco Imaging Nuclear Medicine/Radiopharmaceuticals Sales (K Units) , Revenue (Million USD) , Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bracco Imaging Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Bracco Imaging Nuclear Medicine/Radiopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Bracco Imaging Nuclear Medicine/Radiopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Mallinckrodt Nuclear Medicine/Radiopharmaceuticals Basic Information List
Table Mallinckrodt Nuclear Medicine/Radiopharmaceuticals Sales (K Units) , Revenue (Million USD) , Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mallinckrodt Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Mallinckrodt Nuclear Medicine/Radiopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Mallinckrodt Nuclear Medicine/Radiopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceuticals Basic Information List
Table Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceuticals Sales (K Units) , Revenue (Million USD) , Price (USD/Unit) and Gross Margin (2012-2017)
Figure Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Bayer Nuclear Medicine/Radiopharmaceuticals Basic Information List
Table Bayer Nuclear Medicine/Radiopharmaceuticals Sales (K Units) , Revenue (Million USD) , Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Bayer Nuclear Medicine/Radiopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Bayer Nuclear Medicine/Radiopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Triad Isotopes Nuclear Medicine/Radiopharmaceuticals Basic Information List
Table Triad Isotopes Nuclear Medicine/Radiopharmaceuticals Sales (K Units) , Revenue (Million USD) , Price (USD/Unit) and Gross Margin (2012-2017)
Figure Triad Isotopes Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Triad Isotopes Nuclear Medicine/Radiopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Triad Isotopes Nuclear Medicine/Radiopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Nordion Nuclear Medicine/Radiopharmaceuticals Basic Information List
Table Nordion Nuclear Medicine/Radiopharmaceuticals Sales (K Units) , Revenue (Million USD) , Price (USD/Unit) and Gross Margin (2012-2017)
Figure Nordion Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Nordion Nuclear Medicine/Radiopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Nordion Nuclear Medicine/Radiopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Jubilant Pharma Nuclear Medicine/Radiopharmaceuticals Basic Information List
Table Jubilant Pharma Nuclear Medicine/Radiopharmaceuticals Sales (K Units) , Revenue (Million USD) , Price (USD/Unit) and Gross Margin (2012-2017)
Figure Jubilant Pharma Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Jubilant Pharma Nuclear Medicine/Radiopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Jubilant Pharma Nuclear Medicine/Radiopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Eli Lilly Nuclear Medicine/Radiopharmaceuticals Basic Information List
Table Eli Lilly Nuclear Medicine/Radiopharmaceuticals Sales (K Units) , Revenue (Million USD) , Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Eli Lilly Nuclear Medicine/Radiopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Eli Lilly Nuclear Medicine/Radiopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Siemens Nuclear Medicine/Radiopharmaceuticals Basic Information List
Table Siemens Nuclear Medicine/Radiopharmaceuticals Sales (K Units) , Revenue (Million USD) , Price (USD/Unit) and Gross Margin (2012-2017)
Figure Siemens Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Siemens Nuclear Medicine/Radiopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Siemens Nuclear Medicine/Radiopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Basic Information List
Table Dongcheng Nuclear Medicine/Radiopharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nuclear Medicine/Radiopharmaceuticals
Figure Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceuticals
Figure Nuclear Medicine/Radiopharmaceuticals Industrial Chain Analysis
Table Raw Materials Sources of Nuclear Medicine/Radiopharmaceuticals Major Manufacturers in 2016
Table Major Buyers of Nuclear Medicine/Radiopharmaceuticals
Table Distributors/Traders List
Figure EMEA Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Nuclear Medicine/Radiopharmaceuticals Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Nuclear Medicine/Radiopharmaceuticals Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Nuclear Medicine/Radiopharmaceuticals Sales Market Share Forecast by Region (2017-2022)
Table EMEA Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Nuclear Medicine/Radiopharmaceuticals Revenue Market Share Forecast by Region (2017-2022)
Table Europe Nuclear Medicine/Radiopharmaceuticals Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share Forecast by Countries (2017-2022)
Table Europe Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Nuclear Medicine/Radiopharmaceuticals Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Nuclear Medicine/Radiopharmaceuticals Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Nuclear Medicine/Radiopharmaceuticals Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Nuclear Medicine/Radiopharmaceuticals Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share Forecast by Countries (2017-2022)
Table Africa Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Nuclear Medicine/Radiopharmaceuticals Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Nuclear Medicine/Radiopharmaceuticals Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Nuclear Medicine/Radiopharmaceuticals Sales Market Share Forecast by Type (2017-2022)
Table EMEA Nuclear Medicine/Radiopharmaceuticals Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Nuclear Medicine/Radiopharmaceuticals Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...